These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25624991)

  • 21. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
    Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
    Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
    Lv H; Lv G; Han Q; Yang W; Wang H
    Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of miRNA sponges in hepatocellular carcinoma.
    Li D; Zhang J; Li J
    Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism.
    Liu YR; Tang RX; Huang WT; Ren FH; He RQ; Yang LH; Luo DZ; Dang YW; Chen G
    World J Hepatol; 2015 Dec; 7(28):2781-91. PubMed ID: 26668690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease.
    Xue M; Zhuo Y; Shan B
    Methods Mol Biol; 2017; 1617():1-25. PubMed ID: 28540673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role and clinical implications of microRNAs in hepatocellular carcinoma.
    Zhao X; Yang Z; Li G; Li D; Zhao Y; Wu Y; Robson SC; He L; Xu Y; Miao R; Zhao H
    Sci China Life Sci; 2012 Oct; 55(10):906-19. PubMed ID: 23108868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.
    Gong Q; Su G
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.
    Otsuka M; Kishikawa T; Yoshikawa T; Ohno M; Takata A; Shibata C; Koike K
    J Gastroenterol; 2014 Feb; 49(2):173-84. PubMed ID: 24258409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.
    Xiao Z; Shen J; Zhang L; Li M; Hu W; Cho C
    Oncol Lett; 2018 Mar; 15(3):3395-3402. PubMed ID: 29467864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
    He S; Zhang DC; Wei C
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
    Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
    Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.
    Deng L; Yang SB; Xu FF; Zhang JH
    J Exp Clin Cancer Res; 2015 Feb; 34(1):18. PubMed ID: 25884472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
    Tang XJ; Wang W; Hann SS
    Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.